Drug Shortage Report for SOFRACORT

Last updated on 2020-09-08 History
Report ID 111384
Drug Identification Number 02224623
Brand name SOFRACORT
Common or Proper name Sofracort
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) FRAMYCETIN SULFATE DEXAMETHASONE GRAMICIDIN
Strength(s) 5MG 0.5MG 0.05MG
Dosage form(s) DROPS
Route of administration OPHTHALMIC OTIC OPHTHALMIC OTIC
Packaging size 8ml
ATC code S03CA
ATC description CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION
Reason for shortage Other (Please describe in comments)
Anticipated start date 2020-06-30
Actual start date
Estimated end date 2020-09-14
Actual end date 2020-09-03
Shortage status Resolved
Updated date 2020-09-08
Company comments Delay in production The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2020-09-08 French Compare
v17 2020-09-08 English Compare
v16 2020-09-02 French Compare
v15 2020-09-02 English Compare
v14 2020-08-18 French Compare
v13 2020-08-18 English Compare
v12 2020-07-22 French Compare
v11 2020-07-22 English Compare
v10 2020-07-01 English Compare
v9 2020-06-10 French Compare
v8 2020-06-10 English Compare
v7 2020-05-26 French Compare
v6 2020-05-26 English Compare
v5 2020-05-11 English Compare
v4 2020-04-28 French Compare
v3 2020-04-28 English Compare
v2 2020-04-07 French Compare
v1 2020-04-07 English Compare